Suppr超能文献

评价 ETN PROtect® 在非愈合治疗中的临床应用。

Evaluation of the clinical use of the ETN PROtect® in non-union therapy.

机构信息

ATORG - Aschaffenburg Trauma and Orthopaedic Research Group, Centre for Orthopedics, Trauma Surgery und Sports Medicine, Aschaffenburg-Alzenau, Germany; HTRG - Heidelberg Trauma Research Group, Center for Orthopedics, Trauma and Spinal Cord Injury, Heidelberg University Hospital, Heidelberg, Germany.

HTRG - Heidelberg Trauma Research Group, Center for Orthopedics, Trauma and Spinal Cord Injury, Heidelberg University Hospital, Heidelberg, Germany.

出版信息

Injury. 2019 Aug;50 Suppl 3:32-39. doi: 10.1016/j.injury.2019.07.009. Epub 2019 Aug 1.

Abstract

INTRODUCTION

Non-union of a long bone fracture remains a challenge in orthopaedic and trauma surgery. In the current study, we sought to determine the clinical effectiveness of tibial non-union treatment utilizing an antibiotic-coated intramedullary nail (Expert Tibia Nail (ETN) PROtect®) regarding prevention and treatment of infection and the clinical outcome.

PATIENTS AND METHODS

36 patients suffering from tibial non-unions that were treated with the ETN PROtect® in the course of non-union treatment between February 2010 and March 2015 were included in this clinical observational study. Clinical and radiological examinations were performed preoperatively as well as 4, 6 and 12 weeks and 6 and 12 months postoperatively as part of a standardized follow-up program. Data regarding perioperative complications, weight-bearing capacity, radiological signs of consolidation and subjective health status were assessed at each time point. Laboratory parameters such as C-reactive protein (CRP) and leukocyte count were collected preoperatively in order to assess the patients' risk profile for infection.

RESULTS

Patients had an average of 6.2 previous surgeries and 22 patients (61.1%) had a positive bacterial culture from intraoperatively removed tissue during the first operative treatment. 29 patients (80.6%) achieved full weight-bearing after an average of 7.7 months, furthermore 80.6% of patients achieved osseous consolidation. 3 deep infections occurred, including one amputation. Subjective health status increase based on the SF-12 questionnaire during our follow-up program.

CONCLUSION

The results from the current study indicate that the use of the ETN PROtect® in the applied non-union therapy has a high clinical effectiveness regarding osseous consolidation and time to weight bearing. In addition, the use of gentamicin-coated nails in the treatment of tibial non-unions might contribute to both successful treatment of the underlying infection and prevention of perioperative infection. The gentamicin-coated nail may serve as a beneficial adjunct treatment in the applied non-union therapy in addition to all established techniques in the treatment of infected non-unions.

摘要

简介

长骨骨折不愈合仍然是矫形和创伤外科的一个挑战。在目前的研究中,我们试图确定使用抗生素涂层髓内钉(Expert Tibia Nail (ETN) PROtect®)治疗胫骨不愈合在预防和治疗感染以及临床结果方面的临床效果。

患者和方法

本临床观察研究纳入了 36 名在 2010 年 2 月至 2015 年 3 月期间接受 ETN PROtect®治疗的胫骨不愈合患者。在非愈合治疗过程中进行了术前以及术后 4、6 和 12 周以及 6 和 12 个月的临床和影像学检查,作为标准化随访计划的一部分。在每个时间点评估围手术期并发症、负重能力、骨愈合的影像学迹象和主观健康状况的数据。收集术前 C-反应蛋白(CRP)和白细胞计数等实验室参数,以评估患者感染的风险状况。

结果

患者平均有 6.2 次既往手术,22 名患者(61.1%)在第一次手术中从术中取出的组织中获得了细菌培养阳性。29 名患者(80.6%)平均在 7.7 个月后实现了完全负重,此外 80.6%的患者实现了骨愈合。发生了 3 例深部感染,包括 1 例截肢。在我们的随访计划中,SF-12 问卷的主观健康状况增加。

结论

当前研究的结果表明,在应用的不愈合治疗中使用 ETN PROtect®具有很高的临床效果,在骨愈合和负重时间方面。此外,在胫骨不愈合的治疗中使用庆大霉素涂层钉可能有助于成功治疗潜在感染和预防围手术期感染。庆大霉素涂层钉除了感染性不愈合治疗中的所有既定技术外,还可以作为应用不愈合治疗中的有益辅助治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验